Received Nov 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | AHBVB735AA | — |
| MMR | MEASLES + MUMPS + RUBELLA (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | 0311Z | — |
Potential Engerix-B administration after expiration date; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a patient who received HBV (Engerix B) (batch number AHBVB735AA) for prophylaxis. Co-suspect products included MEASLES VACCINE;MUMPS VACCINE;RUBELLA VACCINE (batch number 0311Z) for prophylaxis. On 15-MAR-2012, the patient received Engerix B and MEASLES VACCINE;MUMPS VACCINE;RUBELLA VACCINE. On 15-MAR-2012, an unknown time after receiving Engerix B and an unknown time after receiving MEASLES VACCINE;MUMPS VACCINE;RUBELLA VACCINE, the patient experienced expired vaccine used (Verbatim: Potential Engerix-B administration after expiration date). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 30-OCT-2025 A health care provider wanted to check the expiration date of an Engerix-B (lot number AHBVB735AA) and MMRV (lot number 0311Z) in order to confirm that they were not administered already expired back in 2012. He declined given patients details for the potential adverse events. No information was found in the system for those two lot numbers.